Document is current
Any future updates will be listed below
-
Authors
Sowa, Naoya
Horie, Takahiro https://orcid.org/0000-0002-6766-750X
Ide, Yuya
Baba, Osamu
Kora, Kengo
Yoshida, Takeshi https://orcid.org/0000-0003-0992-064X
Nakamura, Yujiro
Matsumura, Shigenobu https://orcid.org/0000-0002-7149-1375
Matsushita, Kazuki
Imanaka, Miyako
Zou, Fuquan
Kume, Eitaro
Kojima, Hidenori
Qian, Qiuxian
Kimura, Kayo
Otsuka, Ryotaro
Hara, Noriko
Yamasaki, Tomohiro
Otani, Chiharu
Tsujisaka, Yuta
Takaya, Tomohide https://orcid.org/0000-0002-3610-0906
Nishimura, Chika
Watanabe, Dai
Hasegawa, Koji
Kotera, Jun
Oka, Kozo
Fujita, Ryo
Takemiya, Akihiro
Sasaki, Takashi
Kasahara, Yuuya https://orcid.org/0000-0002-1102-9795
Obika, Satoshi
Kimura, Takeshi
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (17K09860,20K08904,23K07988, 17H04177,20H03675,and 23K27595)
MEXT | JST | Fusion Oriented REsearch for disruptive Science and Technology (JPMJFR235F)
Japan Agency for Medical Research and Development (21ym0126013h0001,23ym0126074h0002, 24ek0210202h0001, 24am0521009)
Daiwa Securities Health Foundation
Takeda Science Foundation
Ono Medical Research Foundation
- License Information
-
More Information
Article History
Received: 27 February 2025
Revised: 30 June 2025
Accepted: 4 July 2025
First Online: 23 July 2025
Disclosure and competing interests statement
: JK, KOk, RF, AT, and TS are employees of Mitsubishi Tanabe Pharma Corporation.
